Safe Bulkers (SB) holder files to sell 26,554 shares under Rule 144
Rhea-AI Filing Summary
Safe Bulkers Inc. is the issuer in a planned resale of common shares under Rule 144. The notice covers 26,554 common shares to be sold through UBS Financial Services Inc., with an aggregate market value of $127,990.28. These shares relate to an issuer that had 102,320,099 shares outstanding and are expected to be sold on the NYSE around 12/23/2025.
The seller acquired these shares over time as compensation from Safe Bulkers Inc., with multiple grant dates between 2009 and 2012. By signing the notice, the seller represents that they are not aware of any material adverse, non‑public information about the company’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does Safe Bulkers (SB) disclose in this Rule 144 notice?
The notice covers a planned sale of 26,554 common shares of Safe Bulkers Inc. stock, with an aggregate market value of $127,990.28, to be sold on the NYSE through UBS Financial Services Inc.
When are the Safe Bulkers (SB) shares expected to be sold under this Form 144?
The planned sale date listed is an approximate date of 12/23/2025, with the shares to be sold on the NYSE.
How many Safe Bulkers (SB) shares are outstanding in this filing?
The filing notes that there are 102,320,099 common shares of Safe Bulkers Inc. outstanding. This is a baseline share count for the issuer.
How were the Safe Bulkers (SB) shares being sold acquired?
The shares were acquired as compensation from Safe Bulkers Inc., with multiple acquisition dates between 2009 and 2012, each recorded as compensation transactions.
Which broker is handling the sale of Safe Bulkers (SB) shares in this Form 144?
The broker named is UBS Financial Services Inc., located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086.
What representation does the seller make in this Safe Bulkers (SB) Form 144?
By signing the notice, the seller represents that they do not know any material adverse information about Safe Bulkers Inc.’s current or prospective operations that has not been publicly disclosed.